BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.450
-0.010 (-0.29%)
Aug 10, 2026, 2:17 PM EDT - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $5.73 million as of August 10, 2026. Its market cap has decreased by -72.35% in one year.
Market Cap
5.73M
Enterprise Value
9.86M
1-Year Change
-72.35%
Ranking
Category
Stock Price
$3.45
ChartMarket Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $5.73M, a decrease of -99.94%. That is a compound annual growth rate of -73.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 5.73M | -82.92% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 6.12M |
| Addex Therapeutics | 6.12M |
| Purple Biotech | 6.10M |
| Pulmatrix | 6.06M |
| Soligenix | 5.81M |
| Enveric Biosciences | 5.71M |
| GeoVax Labs | 5.67M |
| Cadrenal Therapeutics | 5.59M |